|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense): | ||
| Interest income | ||
| Interest expense | ||
| Loss on debt extinguishment | ||
| Other, net | ||
| Total other income, net | ||
| Net loss | ||
| Other comprehensive income (loss): | ||
| Change in fair value attributable to instrument specific credit risk | ||
| Foreign currency translation | ||
| Total other comprehensive income (loss) | ||
| Comprehensive loss | ||
| Net loss per share attributable to common stockholders, basic (in dollars per share) | ||
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | ||
| Weighted-average number of common shares outstanding, basic (in shares) | ||
| Weighted-average number of common shares outstanding, diluted (in shares) |
Loading...
